Live Breaking News & Updates on Acta Pharmacologica Sinica

Stay updated with breaking news from Acta pharmacologica sinica. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

VV116 Versus PAXLOVID Phase III Registrational Trial for Early Treatment of Mild to Moderate COVID-19 in High Risk Patients Reaches Primary Endpoint | Comunicados | Edición USA

VV116 Versus PAXLOVID Phase III Registrational Trial for Early Treatment of Mild to Moderate COVID-19 in High Risk Patients Reaches Primary Endpoint | Comunicados | Edición USA
efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.

United States , San Francisco , Junshi Bioscience , Junshi Biosciences , Zhi Li , Acta Pharmacologica Sinica , Ir Team , Central Asian Center , Chinese Academy Of Sciences , Xinjiang Technical Institute Of Physics , Vigonvita Life Sciences Co Ltd , Pr Team , Institute Of Microbiology The Chinese Academy , Shanghai Institute Of Materia Medica , Wuhan Institute Of Virology , Shanghai Junshi Biosciences Co Ltd , Development Chinese Academy Of Sciences China , Early Treatment , High Risk Patients Reaches Primary , Shanghai Institute , Materia Medica , Chinese Academy , Wuhan Institute , Xinjiang Technical Institute , Drug Discovery , Development Chinese Academy ,

Junshi Biosciences: VV116 Versus PAXLOVID Phase III Registrational Trial for Early Treatment of Mild to Moderate COVID-19 in High Risk Patients Reaches Primary Endpoint

the study reached its primary endpoint(VV116 was statistically superior) and secondary efficacy endpoint VV116 has a favorable safety profile and fewer adverse events than PAXLOVID SHANGHAI ....

United States , Junshi Bioscience , Junshi Biosciences , Zhi Li , Acta Pharmacologica Sinica , Ir Team , Central Asian Center , Chinese Academy Of Sciences , Xinjiang Technical Institute Of Physics , Vigonvita Life Sciences Co Ltd , Pr Team , Shanghai Institute Of Materia Medica , Wuhan Institute Of Virology , Shanghai Junshi Biosciences Co Ltd , Development Chinese Academy Of Sciences China , Shanghai Institute , Materia Medica , Chinese Academy , Wuhan Institute , Xinjiang Technical Institute , Drug Discovery , Development Chinese Academy , China Uzbekistan Medicine Technical Park , Joint Laboratory , Central Asian , North Africa ,